MTOR and cancer: ZVI-NP triggered ferroptosis selectively in cancer cells by suppressing NRF2-mediated cytoprotection program, which was attributed to the ZVI-NP-induced disruption of AMPK/mTOR signaling and activation of GSK3β/β-TrCP-dependent degradation system.